Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation.
about
Leveraging Humanized Animal Models to Understand Human Drug Disposition: Opportunities, Challenges, and Future Directions.Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
P2860
Evaluation of Cytochrome P450 3A4-Mediated Drug-Drug Interaction Potential for Cobimetinib Using Physiologically Based Pharmacokinetic Modeling and Simulation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@en
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@nl
type
label
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@en
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@nl
prefLabel
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@en
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@nl
P2093
P2860
P1476
Evaluation of Cytochrome P450 ...... netic Modeling and Simulation.
@en
P2093
Luna Musib
Mark Dresser
Nageshwar R Budha
Steve Eppler
P2860
P2888
P304
P356
10.1007/S40262-016-0412-5
P577
2016-05-25T00:00:00Z